
Matthew Jason Greenhawt MD
Asthma & Allergic Conditions
Assistant Professor, Internal Medicine, University of Michigan Medical School
Join to View Full Profile
13123 E 16th AveAurora, CO 80045
Phone+1 720-777-1234
Fax+1 720-777-7247
Dr. Greenhawt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MichiganFellowship, Allergy and Immunology, 2006 - 2008
New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2001 - 2004
Tufts University School of MedicineClass of 2001
Certifications & Licensure
CO State Medical License 2015 - 2027
MI State Medical License 2006 - 2016
GA State Medical License 2008 - 2010
NY State Medical License 2003 - 2008
American Board of Allergy and Immunology Allergy & Immunology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Safe Administration of Flu Vaccine to Egg Allergic Children Start of enrollment: 2010 Oct 01
Publications & Presentations
PubMed
- 2 citationsRisk Factors for the Development of Food Allergy in Infants and Children: A Systematic Review and Meta-Analysis.Nazmul Islam, Alexandro W L Chu, Falana Sheriff, Farid Foroutan, Gordon H Guyatt
JAMA Pediatrics. 2026-05-01 - Balancing patient perspectives and evidence in food protein-induced enterocolitis syndrome (FPIES).Marcus Shaker, Aikaterini Anagnostou, Elissa M Abrams, Matthew Greenhawt
Annals of Allergy, Asthma & Immunology. 2026-05-01 - Equity and Anaphylaxis.Elissa M Abrams, Jennifer L P Protudjer, Matthew Greenhawt
Immunology and Allergy Clinics of North America. 2026-05-01
Journal Articles
- Achieving the Quadruple Aim to Deliver Value-Based Allergy Care in an Ever-Evolving Healthcare SystemMatthew Greenhawt, Marcus S Shaker, Annals of Allergy, Asthma & Immunology
- Development and Acceptability of a Shared Decision-Making Tool for Commercial Peanut Allergy TherapiesMatthew Greenhawt, Marcus Shaker, Don A Bukstein, David M Fleischer, David R Stukus, Annals of Allergy, Asthma & Immunology
Authored Content
- Achieving the Quadruple Aim to Deliver Value-Based Allergy Care in an Ever-Evolving Healthcare SystemApril 2020
- Development and Acceptability of a Shared Decision-Making Tool for Commercial Peanut Allergy TherapiesFebruary 2020
- Significant Health Care Cost Associated with Peanut Allergy Diagnostic CodesJanuary 2020
Press Mentions
ACAAI: Peanut Patch Safely Builds Tolerance over 3 Years in Peanut-Allergic ToddlersNovember 10th, 2025
Peanut Patch Treatment Continues to Help Toddlers Safely Build Tolerance over Three YearsOctober 31st, 2025
NEW: Food Allergy Emergency Care Plan Empowers Self-Care and Reduces Health Care CostsAugust 28th, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









